Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.54 |
| ▸ | FPR2 | P25090 | 3/20 | 0.54 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.53 |
| ▸ | MMP2 | P08253 | 4/20 | 0.53 |
| ▸ | MMP9 | P14780 | 3/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL438206 | 1.00 | MME (0.57) | MMENPSR1CYP1A2NAALAD2FPR2 | |
| SCHEMBL7890615 | 1.00 | MME (0.57) | MMENPSR1CYP1A2NAALAD2FPR2 | |
| SCHEMBL438205 | 1.00 | MME (0.57) | MMENPSR1CYP1A2NAALAD2FPR2 | |
| SCHEMBL4603054 | 0.86 | CYP1A2 (0.48) | MMENPSR1CYP1A2NAALAD2FPR2 | |
| SCHEMBL55971 | 0.85 | FOLH1 (0.56) | MMENAALAD2FOLH1L3MBTL1 | |
| SCHEMBL26993397 | 0.85 | EPHX1 (0.53) | MMENPSR1CYP1A2MMP2L3MBTL1 | |
| SCHEMBL55972 | 0.85 | FOLH1 (0.56) | MMENAALAD2FOLH1L3MBTL1 | |
| SCHEMBL8745399 | 0.85 | FPR2 (0.55) | MMENPSR1CYP1A2NAALAD2FPR2 | |
| SCHEMBL3105902 | 0.85 | FOLH1 (0.56) | MMENAALAD2FOLH1L3MBTL1 | |
| SCHEMBL9068541 | 0.83 | MME (0.70) | MMENPSR1CYP1A2NAALAD2FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1781310-B1 | ARTICLES OF PEPTIDE NANOSTRUCTURES AND METHOD OF FORMING THE SAME | UNIV RAMOT (IL) | 2015-10-14 | — | — | EP | claimed |
| US-8927689-B2 | Peptide nanostructures and methods of generating and using the same | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2015-01-06 | — | — | US | claimed |
| US-8796023-B2 | Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2014-08-05 | — | — | US | claimed |
| US-20120063276-A1 | PEPTIDE NANOSTRUCTURES AND METHODS OF GENERATING AND USING THE SAME | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2012-03-15 | — | — | US | claimed |
| US-8017586-B2 | Peptide nanostructures encapsulating a foreign material and method of manufacturing same | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2011-09-13 | — | — | US | claimed |
| US-7786086-B2 | at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2010-08-31 | — | — | US | claimed |
| EP-1781310-A4 | ARTICLES OF PEPTIDE NANOSTRUCTURES AND METHOD OF FORMING THE SAME | UNIV RAMOT (IL) | 2009-07-08 | — | — | EP | claimed |
| US-20090123553-A1 | Peptide nanostructures and methods of generating and using the same | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2009-05-14 | — | — | US | claimed |
| US-20090121709-A1 | Peptide nanostructures encapsulating A foreign material and method of manufacturing same | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2009-05-14 | — | — | US | claimed |
| US-7504383-B2 | Peptide nanostructures encapsulating a foreign material and method of manufacturing same | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2009-03-17 | — | — | US | claimed |
| US-7491699-B2 | Peptide nanostructures and methods of generating and using the same | RAMOT AT TEL AVIV UNIVERSITY LTD. | 2009-02-17 | — | — | US | claimed |
| US-20080009434-A1 | at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2008-01-10 | — | — | US | claimed |
| EP-1781310-A2 | ARTICLES OF PEPTIDE NANOSTRUCTURES AND METHOD OF FORMING THE SAME | Ramot at Tel Aviv University Ltd. (IL) | 2007-05-09 | — | — | EP | claimed |
| US-20060079455-A1 | Peptide nanostructures encapsulating a foreign material and method of manufacturing same | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2006-04-13 | — | — | US | claimed |
| US-20060079454-A1 | Peptide nanostructures and methods of generating and using the same | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2006-04-13 | — | — | US | claimed |
| WO-2006027780-A2 | PEPTIDE NANOSTRUCTURES CONTAINING END-CAPPING MODIFIED PEPTIDES AND METHODS OF GENERATING AND USING THE SAME | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2006-03-16 | — | — | WO | claimed |
| WO-2006013552-A2 | ARTICLES OF PEPTIDE NANOSTRUCTURES AND METHOD OF FORMING THE SAME | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2006-02-09 | — | — | WO | claimed |
| US-20240167062-A1 | HYDROGEL SYSTEM FOR CONTROLLING OXYGEN CONCENTRATION | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2024-05-23 | — | — | US | disclosed |
| WO-2006027780-A2 | PEPTIDE NANOSTRUCTURES CONTAINING END-CAPPING MODIFIED PEPTIDES AND METHODS OF GENERATING AND USING THE SAME | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2006-03-16 | — | — | WO | disclosed |
| WO-2006013552-A2 | ARTICLES OF PEPTIDE NANOSTRUCTURES AND METHOD OF FORMING THE SAME | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2006-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240167062-A1 | HYDROGEL SYSTEM FOR CONTROLLING OXYGEN CONCENTRATION | HIF1A, HAO2, EGLN2 | MME 3813/4885NPSR1 600/4885CYP1A2 1425/4885 |
| US-20080009434-A1 | at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody | DNPEP, LNPEP, ANPEP | MME 138/4885NPSR1 2419/4885CYP1A2 4772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.